MELISSA TOULIOS: Open Payments
NPI 1912207036 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 55 payments from 10 companies in 2025. Trend: 2023 $2,077 · 2024 $2,010 · 2025 $1,581
Food & beverage: $1,497Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $433 |
| ABBVIE INC. | 14 | $366 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $268 |
| Ardelyx, Inc. | 12 | $249 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $69 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: TREMFYA, ENTYVIO, IBSRELA, SKYRIZI, COBENFY, RINVOQ, VOQUEZNA, LINZESS.
Industry payments across IL — which companies pay providers there.
